Lipid Nanovectors to Deliver RNA Oligonucleotides in Cancer

被引：30
作者：
Campani, Virginia [1 ]
Salzano, Giuseppina [2 ]
Lusa, Sara [3 ]
De Rosa, Giuseppe [1 ]
机构：
[1] Univ Naples Federico II, Dept Pharm, Via Domenico Montesano 49, I-80131 Naples, Italy
[2] Univ Paris 11, CNRS, Inst Mol Sci, Univ Paris Saclay, F-91400 Orsay, France
[3] Univ Naples 2, Dept Biochem Biophys & Gen Pathol, I-80138 Naples, Italy
来源：
NANOMATERIALS | 2016年 / 6卷 / 07期
关键词：
nucleic acid; cationic liposomes; stable nucleic acid lipid particles (SNALPs); lipid-nanoparticles; micelles; MULTIFUNCTIONAL POLYMERIC MICELLES; MEDIATED DNA TRANSFECTION; OVERCOME DRUG-RESISTANCE; ANTI-SURVIVIN SIRNA; IN-VIVO; CATIONIC LIPIDS; INTRACELLULAR DELIVERY; GENE DELIVERY; ANTISENSE OLIGONUCLEOTIDES; VIRAL VECTORS;
D O I：
10.3390/nano6070131
中图分类号：
O6 [化学];
学科分类号：
0703 ;
摘要：
The growing knowledge on the mechanisms of gene silencing and gene regulation by non-coding RNAs (ncRNA), mainly small interfering RNA (siRNA) and microRNA (miRNA), is providing a significant boost to the development of new therapeutic strategies for the treatment of cancer. However, the design of RNA-based therapeutics is hampered by biopharmaceutical issues, thus requiring the use of suitable delivery strategies. In this regards, lipid nanovectors have been successfully investigated to deliver RNA in different forms of cancer. Compared to other biomaterials, lipids offer advantages such as biocompatibility, biodegradability, easy production, low cost, limited toxicity and immunogenicity. The possibility to formulate these materials in the form of nanovectors allows overcoming biopharmaceutical issues associated to the therapeutic use of RNA, with the possibility to target tumors. This review takes stock of the main lipid nanovectors proposed to deliver ncRNA. For each considered delivery strategy, the rational design and the most meaningful in vitro and in vivo results are reported and discussed.
引用
收藏
页数：22
相关论文
共 102 条
[21]   Effect of cationic carriers on the pharmacokinetics and tumor localization of nucleic acids after intravenous administration [J].
de Wolf, Holger K. ;
Snel, Cor J. ;
Verbaan, Ferry J. ;
Schiffelers, Raymond M. ;
Hennink, Wim E. ;
Storm, Gert .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2007, 331 (02) :167-175
[22]   Development of edge-activated liposomes for siRNA delivery to human basal epidermis for melanoma therapy [J].
Dorrani, Mania ;
Garbuzenko, Olga B. ;
Minko, Tamara ;
Michniak-Kohn, Bozena .
JOURNAL OF CONTROLLED RELEASE, 2016, 228 :150-158
[23]   Establishment of Lipofection for Studying miRNA Function in Human Adipocytes [J].
Enlund, Eveliina ;
Fischer, Simon ;
Handrick, Rene ;
Otte, Kerstin ;
Debatin, Klaus-Michael ;
Wabitsch, Martin ;
Fischer-Posovszky, Pamela .
PLOS ONE, 2014, 9 (05)
[24]   Phospholipid-modified PEI-based nanocarriers for in vivo siRNA therapeutics against multidrug-resistant tumors [J].
Essex, S. ;
Navarro, G. ;
Sabhachandani, P. ;
Chordia, A. ;
Trivedi, M. ;
Movassaghian, S. ;
Torchilin, V. P. .
GENE THERAPY, 2015, 22 (03) :257-266
[25]  
FELGNER JH, 1994, J BIOL CHEM, V269, P2550
[26]   Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans [J].
Fire, A ;
Xu, SQ ;
Montgomery, MK ;
Kostas, SA ;
Driver, SE ;
Mello, CC .
NATURE, 1998, 391 (6669) :806-811
[27]  
Gao X, 1995, GENE THER, V2, P710
[28]   A NOVEL CATIONIC LIPOSOME REAGENT FOR EFFICIENT TRANSFECTION OF MAMMALIAN-CELLS [J].
GAO, X ;
HUANG, L .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1991, 179 (01) :280-285
[29]   Intratracheal Versus Intravenous Liposomal Delivery of siRNA, Antisense Oligonucleotides and Anticancer Drug [J].
Garbuzenko, Olga B. ;
Saad, Maha ;
Betigeri, Seema ;
Zhang, Min ;
Vetcher, Alexandre A. ;
Soldatenkov, Viatcheslav A. ;
Reimer, David C. ;
Pozharov, Vitaly P. ;
Minko, Tamara .
PHARMACEUTICAL RESEARCH, 2009, 26 (02) :382-394
[30]   On the mechanism whereby cationic lipids promote intracellular delivery of polynucleic acids [J].
Hafez, IM ;
Maurer, N ;
Cullis, PR .
GENE THERAPY, 2001, 8 (15) :1188-1196
12345678910